Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 2Phase 1/2 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Other neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 60Leukemia, Myeloid, Acute 40Leukemia 30Leukemia, Myelogenous, Chronic, BCR-ABL Positive 28Hematologic Neoplasms 23Leukemia, Lymphocytic, Chronic, B-Cell 16Lymphoma 11Febrile Neutropenia 10Myelodysplastic Syndromes 9Recurrence 8Neoplasms 8Lymphoma, Non-Hodgkin 8Leukemia, Myeloid, Chronic-Phase 8Leukemia, Promyelocytic, Acute 7Neoplasm, Residual 6Neutropenia 5Neoplasms, Plasma Cell 4Graft vs Host Disease 4Philadelphia Chromosome 3Mycoses 3Lymphoma, Mantle-Cell 3Leukemia, B-Cell 3Invasive Fungal Infections 3Bronchiolitis Obliterans Syndrome 3Blast Crisis 3Waldenstrom Macroglobulinemia 2Vomiting 2Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Tumor Lysis Syndrome 2

Interventions

peginterferon alfa-2b 1Zidovudine 1Valproic Acid 1Interferon alpha-2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × HTLV-I Infections × Other hematologic neoplasm × Clear all
NCT03226119 2018-09-13

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

MP Biomedicals, LLC

Phase 4 Completed
150 enrolled
LymphoidOther hematologic neoplasm

Leukemia-Lymphoma, Adult T-Cell, HTLV-I Infections, HTLV-II Infections, Paraparesis, Tropical Spastic

NCT00854581 2018-04-17

Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma

University of Miami

Phase 4 Terminated
13 enrolled 15 charts
LymphoidOther hematologic neoplasmOther neoplasm

Lymphoma, Precancerous Conditions, HTLV-I Infections, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡